ICU Sedation After Coronary Artery Bypass Graft Surgery: Dexmedetomidine-based Versus Propofol-based Sedation Regimens
Overview
Affiliations
Objective: To compare dexmedetomidine-based to propofol-based sedation after coronary artery bypass graft (CABG) surgery in the intensive care unit (ICU).
Design: Randomized, open label.
Setting: Twenty-five centers in the United States and Canada.
Participants: Two hundred ninety-five adults undergoing CABG surgery.
Interventions: At sternal closure, patients in group A received 1.0 microg/kg of dexmedetomidine over 20 minutes and then 0.2 to 0.7 microg/kg/h to maintain a Ramsay sedation score > or =3 during assisted ventilation and > or =2 after extubation. Patients could be given propofol for additional sedation if necessary; group B patients received propofol-based care according to each investigator's standard practice.
Measurements And Main Results: Mean sedation levels were within target ranges in both groups. Mean times to weaning and extubation were similar, although fewer dexmedetomidine patients remained on the ventilator beyond 8 hours. Morphine use was significantly reduced in the dexmedetomidine group. Only 28% of the dexmedetomidine patients required morphine for pain relief while ventilated versus 69% of propofol-based patients (p < 0.001). Propofol patients required 4 times the mean dose of morphine while in the ICU. Mean blood pressure increased initially in both groups, then decreased to 3 mmHg below baseline in dexmedetomidine patients; mean arterial pressure remained at 9 mmHg above baseline in propofol patients. No ventricular tachycardia occurred in the dexmedetomidine-sedated patients compared with 5% of the propofol patients (p = 0.007). Respiratory rates and blood gases were similar. Fewer dexmedetomidine patients received beta-blockers (p = 0.014), antiemetics (p = 0.015), nonsteroidal anti-inflammatory drugs (p < 0.001), epinephrine (p = 0.030), or high-dose diuretics (p < 0.001).
Conclusion: Dexmedetomidine provided safe and effective sedation for post-CABG surgical patients and significantly reduced the use of analgesics, beta-blockers, antiemetics, epinephrine, and diuretics.
Petitjeans F, Longrois D, Ghignone M, Quintin L J Crit Care Med (Targu Mures). 2025; 10(4):291-315.
PMID: 39916864 PMC: 11799322. DOI: 10.2478/jccm-2024-0035.
Petitjeans F, Leroy S, Pichot C, Ghignone M, Quintin L, Longrois D Eur J Anaesthesiol Intensive Care. 2025; 2(5):e0030.
PMID: 39916810 PMC: 11783659. DOI: 10.1097/EA9.0000000000000030.
Peng J, Wu Y, Li L, Xia P, Yu P, Zhang J Front Cardiovasc Med. 2024; 11:1433841.
PMID: 39450236 PMC: 11499117. DOI: 10.3389/fcvm.2024.1433841.
Weinberg L, Johnston S, Fletcher L, Caragata R, Hazard R, Le P J Cardiothorac Surg. 2024; 19(1):375.
PMID: 38918868 PMC: 11202251. DOI: 10.1186/s13019-024-02935-0.
Ventricular Tachycardia Following Ephedrine During Dexmedetomidine Dental Procedural Sedation.
Abe S, Suzuki K, Hamamura M, Tamanoi T, Takahashi K, Wakamatsu K Anesth Prog. 2024; 70(4):184-190.
PMID: 38221700 PMC: 11088198. DOI: 10.2344/anpr-70-03-04.